Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

SCOLR Pharma, Inc. (SCLR)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-11Jun-30-11Mar-31-11Dec-31-10Sep-30-10Jun-30-10Mar-31-10Dec-31-09
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -6.8-7.0-7.0-6.7-3.9-4.5-5.6-6.7
Depreciation and amortization  0.40.40.40.40.30.30.40.4
Stock-based compensation  0.00.0 0.0-0.80.1 0.0
Change in working capital   [+]-0.8-0.9-0.6-0.6-0.4-0.3-0.2-0.4
Other operating activities  1.81.72.11.91.60.91.31.7
Cash from operations  -5.4-5.8-5.0-5.0-3.2-3.6-4.2-5.0
   
Capital expenditures   [+]0.00.00.00.0-0.1-0.1-0.1-0.1
Purchases of intangible assets  0.00.0  -0.3-0.2  
Other cash from investing   0.40.20.20.30.2-0.10.0
Cash from investing  0.50.5-0.1-0.1-0.1-0.1-0.2-0.1
   
Issuance of common stock, net     3.7 3.8  
Other cash from financing   -2.6 -3.8 0.0  
Cash from financing  -2.8-2.8-0.1-0.13.83.8-0.1-0.1
   
Free cash flow  -5.4-5.8-5.0-5.0-3.3-3.7-4.3-5.1
        Per share (diluted)  ($0.12)($0.13)($0.11)($0.11)($0.07)($0.08)($0.10)($0.12)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy